Partners

We form R&D collaborations with pharmaceutical companies and biotechnology companies to discover novel disease mechanisms with our cross-species in silico tools. Some collaborations are specific to biomarker discovery. With some companies, we provide tools to address specific needs without a co-development partnership agreement. Partnering with a CPA accredited service provider means CrossGen can provide a complete package of biomarker discovery to biomarker validation. The following companies have collaboration/service arrangements with CrossGen;

Source Bioscience plc, Nottingham, UK

http://www.sourcebioscience.com/

Quotient Bioresearch, Cambridge, UK

http://www.quotientbioresearch.com/bioanalysis/central-lab